OmniaBio

Currently Hiring

About the company

OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022.

OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing.

OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.

Open jobs

Browse and apply for open jobs at OmniaBio.

1 jobs found